Jak/Stat Pathway
Stat5 (3H7) Rabbit mAb
|
イイネ!(0)
|
|
| CSTコード |
包装 |
希望納入価格 (円) |
国内在庫  |
ご登録代理店情報  カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更は こちら。 |
| #9358S | 100 μL | 46,000 | |
|
Stat5抗体製品一覧
9358 の推奨プロトコール
最適な結果を得るために:Cell Signaling Technology (CST) 社は、各製品の推奨プロトコールを使用することを強くお薦めいたします。
推奨プロトコールはCST社内試験の徹底的なバリデーションに基づいて作成されておりますので、正確かつ再現性の高い結果が得られます。
注:各製品に最適化されたプロトコールをリンクしています。
| | |
-
9358:
-
ChIP Agarose
ChIP Magnetic
Immunoprecipitation
Western Blotting
| 用途(希釈倍率) | |
| ウェスタンブロッティング(1:1,000)、免疫沈降(1:50)、ChIP(1:50) |
| 特異性・感度 | |
| 内在性レベルのStat5α、βタンパク質を検出します。 |
| 使用抗原 | |
| ヒトStat5タンパク質の中央領域(合成ペプチド) |
Western Blotting

Western blot analysis of extracts from HeLa, L929 and PC12 cells, using Stat5 (3H7) Rabbit mAb.
Chromatin IP

Chromatin immunoprecipitations were performed with cross-linked chromatin from 4 x 106 BaF3 cells starved of IL-3 for 6 hours followed by induction with IL-3 for 45 minutes, and either 20 μl of Stat5 Antibody or 2 μl of Normal Rabbit IgG #2729 using SimpleChIP® Enzymatic Chromatin IP Kit (Magnetic Beads) #9003. The enriched DNA was quantified by real-time PCR using SimpleChIP® Mouse CIS Intron 1 Primers #5131, mouse SOCS-3 promoter primers, and SimpleChIP® Mouse RPL30 Intron 2 Primers #7015. The amount of immunoprecipitated DNA in each sample is represented as signal relative to the total amount of input chromatin, which is equivalent to one.
Stat5 is activated in response to a wide variety of ligands including IL-2, GM-CSF, growth hormone and prolactin. Phosphorylation at Tyr694 is obligatory for Stat5 activation (1,2). This phosphorylation is mediated by Src upon erythropoietin stimulation (3). Stat5 is constitutively active in some leukemic cell types (4). Phosphorylated Stat5 is found in some endothelial cells treated with IL-3, which suggests its involvement in angiogenesis and cell motility (5). Stat5a and Stat5b are independently regulated and activated in various cell types. For instance, interferon treatment predominantly activates Stat5a in U-937 cells and Stat5b in HeLa cells (6).
-
Gouilleux, F. et al. (1994) EMBO J. 13, 4361-4369.
-
Wakao, H. et al. (1994) EMBO J. 13, 2182-2191.
-
Okutani, Y. et al. (2001) Oncogene 20, 6643-6650.
-
Demoulin, J.B. et al. (1999) J. Biol. Chem. 274, 25855-25861.
-
Dentelli, P. et al. (1999) J. Immunol. 163, 2151-2159.
-
Meinke, A. et al. (1996) Mol. Cell. Biol. 16, 6937-6944.